Intrommune Therapeutics

New York, United States

Intrommune Therapeutics is a New York-based biotechnology company.

Feb 2022

Series B

Biotechnology Health Care Therapeutics

Top Investors

Chemical Angel Network Robin Hood Ventures Red Bear Angels Timberline Investments

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Intrommune Therapeutics

Who are Intrommune Therapeutics's investors?

Intrommune Therapeutics's investors include Chemical Angel Network, Robin Hood Ventures, Red Bear Angels, Timberline Investments.

Where is Intrommune Therapeutics headquartered?

Intrommune Therapeutics is headquartered in New York, United States.

What does Intrommune Therapeutics do?

Intrommune Therapeutics is a New York-based biotechnology company.

What stage is Intrommune Therapeutics at?

Intrommune Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 8, 2022.

MLA

"Intrommune Therapeutics — Funding & Investors." VCBacked, February 8, 2022, https://www.vcbacked.co/company/intrommune-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2022). Intrommune Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/intrommune-therapeutics

Wikipedia (cite web)

{{cite web |title=Intrommune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intrommune-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 8, 2022.